| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0007 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.097 | 0.0008 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.098 | 0.001 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.089 | 0.001 |